Want to see RMTG full AI Analyst Report?
Total Valuation
Regenerative Medical Technology Group has a market cap or net worth of $689.80K. The enterprise value is $19.90.
Market Cap$689.80K
Enterprise Value$19.90
Share Statistics
Regenerative Medical Technology Group has 13,138,968 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,138,968
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Regenerative Medical Technology Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 5.71%.
Return on Equity (ROE)0.22
Return on Assets (ROA)-1.74
Return on Invested Capital (ROIC)5.71%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee5.10M
Profits Per Employee-7.81M
Employee Count1
Asset Turnover1.14
Inventory Turnover14.37
Valuation Ratios
The current PE Ratio of Regenerative Medical Technology Group is ―. Regenerative Medical Technology Group’s PEG ratio is -0.00193.
PE Ratio―
PS Ratio0.12
PB Ratio-0.02
Price to Fair Value-0.02
Price to FCF-0.47
Price to Operating Cash Flow3.45
PEG Ratio-0.00193
Income Statement
In the last 12 months, Regenerative Medical Technology Group had revenue of 5.10M and earned -7.81M in profits. Earnings per share was -0.62.
Revenue5.10M
Gross Profit2.81M
Operating Income-867.16K
Pretax Income-7.81M
Net Income-7.81M
EBITDA-83.56K
Earnings Per Share (EPS)-0.62
Cash Flow
In the last 12 months, operating cash flow was 268.56K and capital expenditures -850.89K, giving a free cash flow of -582.33K billion.
Operating Cash Flow268.56K
Free Cash Flow-582.33K
Free Cash Flow per Share-0.04
Dividends & Yields
Regenerative Medical Technology Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.00
52-Week Price Change11.32%
50-Day Moving Average0.06
200-Day Moving Average0.04
Relative Strength Index (RSI)49.16
Average Volume (3m)8.37K
Important Dates
Regenerative Medical Technology Group upcoming earnings date is Aug 20, 2026, Before Open (Confirmed).
Last Earnings DateJun 10, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
Regenerative Medical Technology Group as a current ratio of 0.03, with Debt / Equity ratio of -55.38%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap31.61
Net Debt to EBITDA-222.73
Interest Coverage Ratio-0.12
Taxes
In the past 12 months, Regenerative Medical Technology Group has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Regenerative Medical Technology Group EV to EBITDA ratio is -230.14, with an EV/FCF ratio of -14.69.
EV to Sales3.77
EV to EBITDA-230.14
EV to Free Cash Flow-14.69
EV to Operating Cash Flow-27.22
Balance Sheet
Regenerative Medical Technology Group has $1.32M in cash and marketable securities with $21.74M in debt, giving a net cash position of -$20.42M billion.
Cash & Marketable Securities$1.32M
Total Debt$21.74M
Net Cash-$20.42M
Net Cash Per Share-$1.55
Tangible Book Value Per Share-$2.89
Margins
Gross margin is 59.76%, with operating margin of -17.00%, and net profit margin of -153.18%.
Gross Margin59.76%
Operating Margin-17.00%
Pretax Margin-153.18%
Net Profit Margin-153.18%
EBITDA Margin-1.64%
EBIT Margin-7.15%
Analyst Forecast
The average price target for Regenerative Medical Technology Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast36.96%
EPS Growth Forecast-79.17%